Skip to main content
Journal of Diabetes and Metabolic Disorders logoLink to Journal of Diabetes and Metabolic Disorders
. 2019 Jun 27;18(2):363–369. doi: 10.1007/s40200-019-00420-3

Quantitative analysis of key periodontopathic bacteria in gestational diabetic and non-diabetic women

Kavitha Ganiger 1, Srirangarajan Sridharan 2,, Aparna Rahul 2, Aparna Satyanarayana 2
PMCID: PMC6915202  PMID: 31890661

Abstract

Purpose

The aim of this study is to compare the periodontal status and quantify Porphyromonas gingivalis (Pg) and Prevotella intermedia (Pi) from plaque samples of both gestational diabetic mellitus (GDM) and non diabetic pregnant women.

Materials and methods

Sixty first time pregnant women were selected after adjusting for age, duration of pregnancy and educational status. They were then categorized into gestational diabetic women (GDM) (Group A) and healthy pregnant women (non GDM) (Group B). Periodontal examination was done by assessing gingival index, periodontal disease index and probing depth. Microbial analysis on sub-gingival plaque was performed using polymerase chain reaction (PCR). Statistical analysis was done by student t test, chi square test and Fischer exact test.

Results

Group A showed higher gingival index, probing depth and periodontal disease index scores than group B at p < 0.001. Pg was detected in 80% of group A and 40% of group B. Amongst these; it was measured over 2.0 × 104 in 33% of group A, while in the group B it never scored more than 1.0 × 104. While Pi were also detected in 73% of group A women and 40% Group B women but quantification showed Pi > 2.0 × 104 in more number of group A women.

Conclusion

This study showed that there is significant association between the severity of periodontal disease and increased levels of Pg and Pi in gestational diabetic women.

Keywords: Gestational diabetes, Periodontal disease, Pregnancy, Periodontopathogens

Introduction

Maternal glucose disorders (MGD) during pregnancy includes gestational diabetic mellitus (GDM), impaired glucose intolerance (IGT) and pre-pregnancy Type 2 diabetes [1]. GDM is defined as glucose intolerance with onset or first diagnosis during pregnancy; it is characterized by pancreatic cell function that is insufficient to meet the body’s insulin needs [2]. Thus, GDM often holds great potential as a condition to study the pathogenesis of diabetes and to develop test strategies for its prevention. Miscarriage, pre-eclampsia and preterm labour is more common in women with GDM [3, 4] Stillbirth, congenital malformations, macrosomia, birth injury, perinatal mortality and postnatal adaptation problems such as hypoglycaemia are more common in babies born to women with pre-existing diabetes [5]. Despite advances in prenatal care and increased public awareness, adverse pregnancy outcomes are still present as a major public health problem worldwide. Research on the impact of periodontal disease on pregnancy complications has been debated [6, 7]. Infection, therefore, represents an important and frequent contributor to complications of pregnancy. Key periodontopathic bacteria have been associated with various other systemic conditions such as cardiovascular disease, diabetes mellitus, and osteoporosis [8].

Various periodontal pathogens has been listed to be associated with poor pregnancy outcomes [9] and accumulated evidences have implicated the role of Porphyromonas gingivalis (Pg), Tannerella forsythensis, Treponema denticola and Prevotella intermedia (Pi) in pregnancy related complication like preterm delivery [1012]. Accurate quantification of individual bacterial species in dental plaque samples are needed to understand the bacterial etiology of periodontitis and for implicating periodontitis to systemic diseases. Hematogenous spread of Pi and Pg to distant sites away from oral cavity have been demonstrated in patients with chronic periodontits and even after mastication, causing recurrent bacteremias [13]. The frequency of Pg isolation from periodontal healthy individuals is sufficiently rare and that is why Pg is not considered as a member of the normal healthy oral microbial flora [12, 13].

Polymerase Chain Reaction (PCR) allows the determination of the total number of bacterial cells present in a complex sample so that the percentage of the particular bacteria can be determined. Studies have evaluated the usefulness of detection and quantification of the bacterial DNA in plaque samples with different techniques. Conventional semi quantitative PCR demonstrated sufficient sensitivity and specificity for microbiological examination of periodontal disease [14]. With this background, we in this case control study aimed to compare the periodontal status and quantitatively analyze Pg and Pi amongst GDM and non-GDM pregnant women.

Materials and methods

Source of data

This study was carried out in the Department of Periodontics, Bangalore Institute of Dental Sciences and in the Department of Obstetrics and Gynecology (OBG) and Endocrinology, St. John’s Hospital (October 2010 to June 2011). All pregnant women with similar socio economic status enrolled for prenatal program were screened for GDM. The individuals were explained in detail regarding the study protocol; follow up periods and the investigations. Sixty individuals who volunteered to be part of the study signed an informed consent and registered for the study.

Inclusion Criteria:

  1. Females aged 20–30 yrs.

  2. First pregnancy

  3. Diagnosed with Diabetes mellitus during pregnancy.

  4. Have more than 20 teeth excluding third molars.

  5. Individuals willing to participate in the study.

Exclusion Criteria

  1. Pre existing diabetic patient.

  2. Previous history of chronic infection or acute infection.

  3. History of miscarriage or medical termination of pregnancy.

  4. Smoking and alcohol consumption.

  5. Patients with recent previous history of periodontal therapy.

  6. Patients with positive medical history for cardiovascular disease, bleeding disorders and coagulation disorders.

The physician in accordance with the current American Diabetes Association criteria diagnosed GDM. [15] The protocol followed was as follows.

  1. Screening at 24–48 weeks (for women not previously diagnosed with overt diabetes)

  2. Perform 75 g OGTT with plasma glucose measurement

  3. Test in the morning after patient has fasted for ≥8 h.

  4. Repeat test at 1 and 2 h after initial measurement.

Diagnosis is confirmed when the plasma glucose levels meet or exceed fasting 92 mg/dl, 1 h 180 mg/dl and 2 h 153 mg/dl.

After fulfilling the inclusion criteria and voluntarily agreeing to participate in the study the participants were grouped into

  • Group A: Gestational diabetic women.

  • Group B: non-diabetic pregnant women.

Collection of blood samples

5 ml of blood was collected from anticubital vein of all individuals and was transferred into anticoagulant coated vaccutainers for analysis of fasting, postprandial blood sugar and glycosylated hemoglobin levels.

Clinical examination

Periodontal measurements included full mouth gingival index (GI) [16], probing pocket depth (PD), Periodontal disease index (PDI) by Ramfjord (1959) [17], Oral examination was done by a single experienced periodontist (P) and PD was recorded using UNC 15 periodontal probe*(HuFriedy IL, Chicago) and sites with pseudo pocketing were not considered. The measurements were carried out at six sites per tooth (mesiobuccal, midbuccal, distobuccal, mesiolingual, midlingual and distolingual) of all teeth. Each pocket was probed twice to replicate measurements. A third measurement was made if there was a ≥ 0.5-mm difference between the first two measurements. The median of the two or three measurement was used in the data analyses. Chronic periodontits was defined using CDC working definition accordingly as PD ≥ 5 mm or CAL ≥ 4 mm in at least six proximal sites [18].

Collection of subgingival plaque samples

Sub-gingival plaque samples were collected using a sterile gracey curette. Curette was inserted parallel to long axis of tooth sub gingivally, into the deepest portion of the periodontal pocket and then moved coronally by scraping along the root surface. The plaque samples were then transferred in vials containing thioglycollate transport media, for microbial analysis.

DNA extraction procedure from plaque sample

  1. Plaque sample was crushed with sterile blade and transferred in tube containing Tris-Borate-EDTA buffer (T.E)

  2. Centrifuged at 50000 rpm for 2 min.

  3. Supernatant.was discarded and fresh 200 μl T.E. buffer was added and centrifuged for 3–4 min.

  4. Same procedure was repeated for three- four times with fresh T.E. buffer.

  5. Supernatant was discarded and 500micro liter lysis buffer 1 was added and centrifuged at 5000 rpm.

  6. Supernatant was discarded and 50 micro liter lysis buffer 2 and 5 micro liter proteinase K was added and then kept in water bath for 2 h.th, after this it was kept in boiling water bath for 10 min at 90 °C.

  7. Obtained DNA was stored at -20 °C.

Detection of pathogens

After extraction of the DNA it was amplified using DNA polymerase with a primer. The selection of suitable primers and PCR products was done using program PRIME (Genetic computer groups, Madison, Wis). The strains used for Pg were ATCC 33277 and for Pi was ATCC 25611. DNA primers (Bioserve molecular services U.SA) that anneal with nucleotide base sequences specific for the target organism was used (Table 1). The sequenced DNA was detected using conventional semi quantitative PCR and visualized using agarose gel electrophoresis. DNA from the standard strain with and without template served as positive and negative controls. The loading amount for the PCR was set at 100ngm. The band size of test samples was identified by comparing it with DNA ladder.

Table 1.

Specific primers used

Bacteria Sequence Amplicon size (base pairs)
Pg

AGG CAG CTT GCC ATA CTG CG

ACT GTT AGC AAC TAC CGA TGT

404
Pi

AAC GGC ATT ATG TGC TTG CAC

CTC AAG TCC GCC AGT TCG CG

589

Statistical analysis

Power analysis

The sample size is estimated using G power software version 3.1.9.2, the effect size to be assessed between the groups is 80% (d = 0.80), the margin of error was set at 5% (0.05), allocation ratio N2/N1 = 1. The total sample size obtained with the present estimation is 52 with 26 samples in each group, hence the sample size in each group were rounded off to 30.

In the present study descriptive statistical analysis was carried out by Student t test (two tailed, independent), to find the significance of study parameters on continuous scale between two groups (Inter group analysis) on metric parameters. Chi-square test for independence was used to determine the relationship between two variables of a sample. Fisher Exact test was used to test the significance of the association.

Results

80% of subjects with GDM in group A were in third trimester followed by 10% in first and second trimester. While in group B 63.3% of the subjects were in third trimester while 36.7% in second trimester. The mean age group was 28.07 ± 3.75 years and 24.67 ± 3.69 years for subjects in Group A and B respectively. The mean value of fasting blood glucose and random blood glucose in group A was 122.27 ± 14.11 mg/dl and 181.33 ± 38.74 mg/dl respectively where as in group B, it was 92.70 ± 13.11 mg/dl and 111.63 ± 18.99 mg/dl respectively. The mean value of glycosylated hemoglobin in group A was 7.63 ± 2.31% showing moderate glycemic control; the corresponding values in group B was 4.61 ± 1.32 (Table 2).

Table 2.

Age and blood sugar values between the two groups

Variable Group A (mean ± SD) Group B (mean ± SD) P value
Age (years) 28.07 ± 3.75 24.67 ± 3.69* <0.001*
Fasting blood sugar (mg/dl) 122.27 ± 14.11 92.70 ± 13.11 <0.001*
Random blood sugar (mg/dl) 181.33 ± 38.74 111.63 ± 18.99 <0.001*
HbA1c (%) 7.63 ± 2.31 4.61 ± 1.32 <0.001*

Group A: Gestational diabetic group

Group B: Healthy pregnant group

HbA1c: Glycosylated haemoglobin

*Statistically significant at p value <0.001

Gingival index showed a mean score of 0.84 ± 0.20 in group A and 0.71 ± 0.15 in group B and the difference was statically significant. Plaque component of periodontal index showed statistically significant difference in mean score 2.16 ± 0.51 in group A and 1.80 ± 0.42 in group B at a P value of 0.004.Mean score of calculus component did not show significant difference in both the groups. There was highly statistically significant difference in the mean score of gingival and periodontal component between group A and B at P value <0.001. The mean probing depth was significantly more in group A (2.29 ± 0.44) when compared with group B (1.99 ± 0.44) (Table 3).

Table 3.

Comparison of gingival index, periodontal index and probing depth in group A and B

Clinical parameters Group A Group B P value
Gingival index 0.84 ± 0.20 0.71 ± 0.15 0.007**
Periodontal index
  Plaque component 2.16 ± 0.51 1.80 ± 0.42 0.004**
  Calculus component 2.15 ± 0.55 1.92 ± 0.55 0.113
  Gingival and periodontal component 2.01 ± 0.39 1.48 ± 0.32 <0.001**
Probing depth 2.29 ± 0.44 1.99 ± 0.44 0.011*

Periodontal index: includes three components in plaque, calculus and gingival-periodontal component

Group A: Gestational diabetic group

Group B: Healthy pregnant group

*Statistically significant

**Highly statistically significant

Pg was detected in 80% of subjects in group A and 40% of subjects in group B. quantification of Pg showed that in group B it never exceeded 1× 104 where as in group A majority of patients showed Pg in the range of >2 × 104. The difference in the amount was significantly more in group A when compared to group B at P value of 0.007 (Table 4).

Table 4.

Detection and quantification of Porphyromonas gingivalis and Prevotella intermedia by polymerase chain reaction between the groups

Bacteria Porphyromonas gingivalis Prevotella intermedia
Group A Group B Group A Group B
Not detected 20.0% 60.0% 26.7% 60.0%
<1.0 × 104 26.7% 40.0% 53.3% 26.7%
1.0–2.1 × 104 20.0% 0 0 6.7%
>2.0 × 104 33.3% 0 20.0% 6.7%
Total 100.0% 100.0% 100.0% 100.0%
P value p = 0.007** p = 0.175

Group A: Gestational diabetic group

Group B: Healthy pregnant group

**Highly statistically significant

Pi was detected in 73.3% of subjects in group A and 40% of subjects in group B. quantification of Pi in both the groups never exceeded 1.0 × 104 in 50% of group A and 26.7% of group B. However counts of >2.0 × 104 was seen significantly higher in group A as compared to group B at P value of P = 0.175 (Table 4).

On comparing the clinical parameters to Pg and Pi it was seen than all the components of periodontal index and PD were slightly higher in subjects whom Pg were detected although not significant statistically. Whereas the difference in values of gingival and periodontal component of Pi in both the groups between the subjects having Pi and the subjects not having Pi in their plaque samples was statistically significant at p value of 0.016 (Tables 5 and 6).

Table 5.

Comparison of Clinical parameters with the Positivity of Porphyromonas gingivalis in group A and B

Clinical parameters Positivity of Porphyromonas gingivalis P value
Not detected Detected
Group A
  Gingival index 0.86 ± 0.10 0.87 ± 0.20 0.947
  Periodontal index
    Plaque component 1.99 ± 0.17 2.04 ± 0.31 0.816
    Calculus component 1.77 ± 0.54 2.04 ± 0.39 0.337
    Gingival and periodontal component 2.39 ± 0.48 1.98 ± 0.46 0.191
  Probing pocket depth 2.39 ± 0.17 2.52 ± 0.37 0.583
Group B
  Gingival index 0.76 ± 0.17 0.69 ± 0.19 0.494
  Periodontal index
    Plaque component 1.72 ± 0.33 1.94 ± 0.39 0.245
    Calculus component 1.83 ± 0.36 1.84 ± 0.53 0.979
    Gingival and periodontal component 1.51 ± 0.45 1.53 ± 0.16 0.949
  Probing pocket depth 2.26 ± 0.34 2.33 ± 0.26 0.646
Table 6.

Comparison of Clinical parameters with the Positivity of Prevotella intermedia in group A and B

Clinical parameters Positivity of Prevotella intermedia P value
Not detected Detected
Group A
  Gingival index 0.77 ± 0.17 0.89 ± 0.18 0.221
  Periodontal index
    • Plaque component 1.92 ± 0.21 2.07 ± 0.30 0.350
    • Calculus component 1.96 ± 0.34 1.99 ± 0.46 0.872
    • Gingival and periodontal compo 1.66 ± 0.14 2.21 ± 0.47 0.044*
  Probing pocket depth 2.39 ± 0.17 2.53 ± 0.39 0.493
Group B
  Gingival index 0.65 ± 0.13 0.87 ± 0.15 0.011*
  Periodontal index
    • Plaque component 1.73 ± 0.39 1.91 ± 0.30 0.363
    • Calculus component 1.85 ± 0.45 1.80 ± 0.40 0.823
    • Gingival and periodontal component 1.35 ± 0.27 1.78 ± 0.32 0.016*
Probing pocket depth 2.41 ± 0.28 2.11 ± 0.26 0.064+

* statistically significant

Discussion

There is a large body of evidence pointing to infection as a key factor in adverse pregnancy outcomes, [1924]. Literature evidence [2530] suggests possible association between periodontal pathogens and adverse pregnancy outcomes in gestational diabetic individuals thus suggesting the importance of periodontal health in pregnant women. However, till date, it is yet not clearly justified whether mere presence or increased number of these key perio-pathogens like Pg and Pi have an impact on the outcome of pregnancy. Hence in this study we decided to quantify both Pg and Pi in healthy and gestational diabetic women and found that 85% of gestational diabetic women showed presence of Pg in sub-gingival microflora and amongst those 53.3% of individuals presented with very high titers of Pg (greater than 1 × 104). While amongst non-diabetic it was not detected in 60% of individuals and even in those detected the titers we lower than 1 × 104. While for Pi it was detected in 74% of the Gestational diabetic and 40% of the non diabetic, of those detected 20% of gestational diabetic showed very higher titers (2 × 104).

We assessed fasting, random blood glucose and glycosylated hemoglobin levels (HbA1c) for both groups, as HbA1c is considered to be a sensitive predictor for the risk for developing gestational diabetes [31]. The average levels of HbA1c of subjects in group A was 7.63 ± 2.31% which showed moderate control of diabetes mellitus (7–8%) and in group B it was 4.61 ± 1.32. The mean age of the subjects in our study was 28.07 ± 3.75 yrs. in group A and 24.67 ± 3.69 yrs. in group B. Maternal age is an established risk factor for GDM, but there is no consensus on the age group mentioned above having significantly increased risk of GDM [28]. The American Diabetes Association has mentioned the age group in which the lowest cut off is ≥25 years as most predictive of GDM [32]. It was also noted in our study that GDM occurred 80% in the third trimester 10% in first and second trimester as in accordance with the study by Seshiah [33].

Both pregnancy and hyperglycemic conditions are known to have effect on plaque ecology [3] and host response [32]. Association of Pg and Pi in periodontal disease and maternal health is well documented and researched [3436]. Pg employs a variety of strategies to control commensal microbiota and direct disease progression and hence regarded as a keystone species [37]. Recent animal studies have shown Pg to be associated with fetal loss in pregnant mice, reduction in fetal weight and increase fetal resorption [38]. In humans Pg DNA has been found in chorionic tissues of high-risk pregnant women [39, 40] and in the amniotic fluid of women bearing pre-term and/or low birth weight infants [39]. One cross-sectional study demonstrated the presence of Pg antigens in five cell types in the placental tissues [12] suggesting that Pg may commonly colonize placental tissue, leading to an inflammatory response contributing to preterm delivery [41]. Studies have shown relationship between Pi and pregnancy associated periodontal disease as it has shown the ability to thrive in progesterone rich environment. Study by Ning-Yan Yang et al. [42] has shown it to be associated with increased progression of periodontal inflammation in adolescents.

Conventional semi quantitative PCR used in our study has shown to be sensitive enough to detect pathogens from clinical specimens, which are below the detection limit by culture technique [43]. Both Pg and Pi were increased in the group A compared to group B. The detection levels of Pg were almost double in the Group A when compared to group B which are similar to studies which demonstrates increased levels of Pg in periodontal tissues of pregnant women. [35, 44, 45]. Levels of Pi were lower than Pg in both the groups however, in-group A Pi show increased detection and values.

GDM patients exhibited higher values of gingival index, periodontal disease index and higher mean PD as compared to non-diabetic control subjects [42, 43]. It was also found that women with GDM had higher periodontal destruction (50%) when compared with healthy pregnant women (37.3%) [43, 44] although there was no statistical difference between the groups. Similar results were shown by Ruiz et al. and Novak et al. [46, 47] Both GDM and periodontal disease can independently affect the outcome of pregnancy and when they are present together, a synergic exposure to inflammatory components can have a greater impact on fetal health [48].

The strength of this study would be its strict inclusion and exclusion criteria and quantitative analysis of both Pg and Pi rather than merely detecting their presence or absence. Limitations include smaller sample size owing to lack of funds, and not correlating these bacteria with the bacterial profile of amniotic fluid of the gestational diabetic individuals. Evaluating these individuals on a longitudinal basis and checking for any adverse pregnancy outcomes if any, quantifying the inflammatory burden, and gathering evidence for hematogenous dissemination could possibly be the next step in this research.

Conclusion

The present study showed that, there is significant association between the severity of periodontal disease and increased levels of Pg and Pi in gestational diabetic women.

Incidence of GDM is more in the third trimester, higher quantity of Pg was seen in GDM group when compared with non- GDM group, which could hypothetically imply that Pg could play a greater role than Pi in adverse pregnancy outcomes and therapeutic strategies thus should target in reducing the numbers of this keystone pathogen.

Acknowledgements

The authors would like to thank Dr. K.P. Suresh, Biostatistician, National Institute of Animal Nutrition and Physiology, Bangalore, India for helping us with the statistical analysis.

Compliance with ethical standards

Conflict of interest

The authors claim no conflict of interest in this study.

Footnotes

Increased levels of Pg and Pi observed in GDM subjects with chronic periodontitis.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Farrell S, Ide M, Wilson RF. The relationship between maternal periodontitis, adverse pregnancy outcome and miscarriage in never smokers. J Clin Periodontol. 2006;33(2):115–120. doi: 10.1111/j.1600-051X.2005.00884.x. [DOI] [PubMed] [Google Scholar]
  • 2.Buchanan TA, Xiang A, Kjos SL, Watanabe R. What is gestational diabetes? Diabetes Care. 2007;30(2):1–7. doi: 10.2337/dc07-s201. [DOI] [PubMed] [Google Scholar]
  • 3.Best LG, Saxena R, Anderson CM, et al. Two variants of the C-reactive protein gene are associated with risk of pre eclampsia in an American Indian population. PLoS ONE. 2013;8:e71231. doi: 10.1371/journal.pone.0071231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Wang Y, Cupul-Uicab LA, Rogan WJ, Eggesbo M, Travlos G, Wilson R, Longnecker MP. Recreational exercise before and during pregnancy in relation to plasma C - reactive protein concentrations in pregnant women. J Phys Act Health. 2015;12:770–775. doi: 10.1123/jpah.2013-0390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Gunderson EP, Quesenberry CP, Jr, Jacobs DR, Jr, Feng J, Lewis CE, Sidney S. Longitudinal study of prepregnancy cardiometabolic risk factors and subsequent risk of gestational diabetes mellitus. The CARDIA study. Am J Epidemiol. 2010;172(10):1131–1143. doi: 10.1093/aje/kwq267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Offenbacher S, Boggess KA, Murtha AP, Jared HL, Lieff S, McKaig RG, Mauriello SM, Moss KL, Beck JD. Progressive periodontal disease and risk of very preterm delivery. Obstet Gynecol. 2006;107(1):29–23. doi: 10.1097/01.AOG.0000190212.87012.96. [DOI] [PubMed] [Google Scholar]
  • 7.Offenbacher S, Bobetsis YA, Barros SP. Exploring the relationship between periodontal disease and pregnancy complications. J Am Dent Assoc. 2006;137:7–13. doi: 10.14219/jada.archive.2006.0403. [DOI] [PubMed] [Google Scholar]
  • 8.Beck JD, Offenbacher S. Systemic effects of periodontitis: epidemiology of periodontal disease and cardiovascular disease. J Periodontol. 2005;76:2089–2100. doi: 10.1902/jop.2005.76.11-S.2089. [DOI] [PubMed] [Google Scholar]
  • 9.Fardini Y, Chung P, Dumm R, Joshi N, Han YW. Transmission of diverse Oral Bacteria to murine placenta: evidence for the oral microbiome as a potential source of intrauterine infection. Infect Immun. 2010;78(5):1789–1796. doi: 10.1128/IAI.01395-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Cassini MA, Pilloni A, Condo SG, Vitali LA, Pasquantonio G, Cerroni L. Periodontal bacteria in the genital tract: are they related to adverse pregnancy outcome? Int J Immunopathol Pharmacol. 2013;26:931–939. doi: 10.1177/039463201302600411. [DOI] [PubMed] [Google Scholar]
  • 11.Ercan E, Eratalay K, Deren O, Gur D, Ozyuncu O, Altun B, Kanlı C, Ozdemir P, Akıncıbay H. Evaluation of periodontal pathogens in amniotic fluid and the role of periodontal disease in pre-term birth and low birth weight. Acta Odontol Scand. 2013;71:553–559. doi: 10.3109/00016357.2012.697576. [DOI] [PubMed] [Google Scholar]
  • 12.Tellapragada Chaitanya, Eshwara Vandana Kalwaje, Acharya Shashidhar, Bhat Parvati, Kamath Asha, Vishwanath Shashidhar, Mukhopadhyay Chiranjay. Prevalence of Clinical Periodontitis and Putative Periodontal Pathogens among South Indian Pregnant Women. International Journal of Microbiology. 2014;2014:1–5. doi: 10.1155/2014/420149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Katz J, Chegini N, Shiverick KT, Lamont RJ. Localization of P. gingivalis in preterm delivery placenta. J Dent Res. 2009;88(6):575–578. doi: 10.1177/0022034509338032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Collins JG, Windely HW, Arnold RR, Offenbacher S. Effects of a Porphyromonas gingivalis infection on inflammatory mediator response and pregnancy outcome in hamsters. Infect Immun. 1994;62(10):4356–4361. doi: 10.1128/iai.62.10.4356-4361.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Oqunleye OK, Davidson KD, Gregg AR, Egerman R. S prenatal outcomes after adopting 1-versus 2 step approach to diagnosing gestational diabetes. J Matern Fetal Neonatal Med. 2016;29:1–5. doi: 10.3109/14767058.2016.1166201. [DOI] [PubMed] [Google Scholar]
  • 16.Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand. 1963;21:533–551. doi: 10.3109/00016356309011240. [DOI] [PubMed] [Google Scholar]
  • 17.Ramfjord SP. Periodontal disease index. J Periodontol. 1967;38:602–610. doi: 10.1902/jop.1967.38.6.602. [DOI] [PubMed] [Google Scholar]
  • 18.Page RC, Eke PI. Case definitions for use in population-based surveillance of periodontitis. J Periodontol. 2007;78:1387–1399. doi: 10.1902/jop.2007.060264. [DOI] [PubMed] [Google Scholar]
  • 19.Minkoff H. Prematurity: infection as an etiologic factor. Obstet Gynecol. 1983;62:137–144. [PubMed] [Google Scholar]
  • 20.Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweet RL. A review of premature birth and subclinical infection. Am J Obstet Gynecol. 1992;166:1515–1528. doi: 10.1016/0002-9378(92)91628-n. [DOI] [PubMed] [Google Scholar]
  • 21.Gibbs RS. The relationship between infections and adverse pregnancy outcomes: an overview. Ann Periodontol. 2001;26:153–163. doi: 10.1902/annals.2001.6.1.153. [DOI] [PubMed] [Google Scholar]
  • 22.Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999;180:499–506. doi: 10.1016/s0002-9378(99)70239-5. [DOI] [PubMed] [Google Scholar]
  • 23.Von Dadelszen P, Magee LA. Could an infectious trigger explain the differential maternal response to the shared placental pathology ofpreeclampsia and normotensive intrauterine growth restriction? Acta Obstet Gynecol Scand. 2002;81:642–648. [PubMed] [Google Scholar]
  • 24.Straka M. Pregnancy and periodontal tissues. Neuro Endocrinol Lett. 2011;32(1):34–38. [PubMed] [Google Scholar]
  • 25.Xiong X, Buekens P, Fraser W, Beck J, Offenbacher S. Periodontal disease and adverse pregnancy outcomes: a systematic review. BJOG. 2006;113:135–143. doi: 10.1111/j.1471-0528.2005.00827.x. [DOI] [PubMed] [Google Scholar]
  • 26.Soskolne WA, Klinger A. The relationship between periodontal diseases and diabetes: an overview. Ann Periodontol. 2001;6:91–98. doi: 10.1902/annals.2001.6.1.91. [DOI] [PubMed] [Google Scholar]
  • 27.Lamster IB, Lalla E, Borgnakke WS, Taylor GW. The relationship between oral health and diabetes mellitus. J Am Dent Assoc. 2008;139(Suppl):19–24. doi: 10.14219/jada.archive.2008.0363. [DOI] [PubMed] [Google Scholar]
  • 28.Xiong X, Buekens P, Vastardis S, Pridjian G. Periodontal disease and gestational diabetes mellitus. Am J Obstet Gynecol. 2006;195:1086–1089. doi: 10.1016/j.ajog.2006.06.035. [DOI] [PubMed] [Google Scholar]
  • 29.Xiong X, Buekens P, Vastardis S, Yu SM. Periodontal disease and pregnancy outcomes:state-of-the-science. Obstet Gynecol Surv. 2007;62:605–615. doi: 10.1097/01.ogx.0000279292.63435.40. [DOI] [PubMed] [Google Scholar]
  • 30.Gestational diabetes mellitus. Am Diabetes Assoc Diabetes Care. 2004;27(Suppl):88–90.
  • 31.Morris MA, Grandis AS, Litton J. Glycosylated hemoglobin: a sensitive indicator of gestational diabetes. Obstet Gynecol. 1986;68(3):357–361. doi: 10.1097/00006250-198609000-00013. [DOI] [PubMed] [Google Scholar]
  • 32.Rodrigues S, Robinson E, Donald KG. Prevalence of gestational diabetes mellitus among James Bay Cree women in northern Quebec. Can Med Assoc J. 2010;160(9):1293–1297. [PMC free article] [PubMed] [Google Scholar]
  • 33.Seshiah VA, Balaji VA, Madhuri S, Balaji A, Paneerselvam A, Arthi TA. Gestational diabetes mellitus manifests in all trimesters of pregnancy. Diabetes Res Clin Pract. 2007;77:482–484. doi: 10.1016/j.diabres.2007.01.001. [DOI] [PubMed] [Google Scholar]
  • 34.Zambon JJ, Reynolds H, Fisher JG, et al. Microbiological and immunological studies of adult periodontitis in patients with non-insulin diabetes mellitus. J Periodontol. 1992;63:274–279. doi: 10.1902/jop.1988.59.1.23. [DOI] [PubMed] [Google Scholar]
  • 35.Gogeneni H, Buduneli N, Ceyhan-Ozturk B, et al. Increased infection with key periodontal pathogens during gestational diabetes mellitus. J Clin Periodontol. 2015;42:506–512. doi: 10.1111/jcpe.12418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Leon R, Silva N, Ovalle A, et al. Detection of Porphyromonas gingivalis in the amniotic fluid in pregnant women with a diagnosis of threatened premature labor. J Periodontol. 2007;78(7):1249–1255. doi: 10.1902/jop.2007.060368. [DOI] [PubMed] [Google Scholar]
  • 37.Hajishengallis G, Liang S, Payne MA, Hashim A, Jotwani R, Eskan MA, McIntosh ML, Alsam A, Kirkwood KL, Lambris JD, Darveau RP, Curtis MA. Low abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe. 2011;10:497–506. doi: 10.1016/j.chom.2011.10.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Schenkein HA, Bradley JL, Purkall DB. Anticardiolipin in Porphyromonas gingivalis antisera causes fetal loss in mice. J Dent Res. 2013;92:814–818. doi: 10.1177/0022034513497959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Barak S, Oettinger-Barak O, Machtei EE, Sprecher H, Ohel G. Evidence of periopathogenic microorganisms in placentas of women with preeclampsia. J Periodontol. 2007;78(4):670–676. doi: 10.1902/jop.2007.060362. [DOI] [PubMed] [Google Scholar]
  • 40.Kunnen A, Van Pampus M, Aarnoudse J, Vander Schans C, Abbas F, Faas M. The effect of Porphyromonas gingivalis lipopolysaccharide on pregnancy in the rat. Oral Dis. 2014;20:591–601. doi: 10.1111/odi.12177. [DOI] [PubMed] [Google Scholar]
  • 41.Dasanayake AP, Chhun N, Tanner AC, et al. Periodontal pathogens and gestational diabetes mellitus. J Dent Res. 2008;87(4):328–333. doi: 10.1177/154405910808700421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Yang N-Y, Zhang Q, Li J-L, Yang S-H, Shi Q. Progression of periodontal inflammation in adolescents is associated with increased number of Porphyromonas gingivalis, Prevotella intermedia, Tannerella forsythensis, and fusobacterium nucleatum. Int J Paediatr Dent. 2014;24:226–233. doi: 10.1111/ipd.12065. [DOI] [PubMed] [Google Scholar]
  • 43.Boutaga K, Van Winkelhoff AJ, Vandenbroucke-Grauls CMJE, Savelkoul PHM. The additional value of real-time PCR in the quantitative detection of periodontal pathogens. J Clin Periodontol. 2006;33:427–433. doi: 10.1111/j.1600-051X.2006.00925.x. [DOI] [PubMed] [Google Scholar]
  • 44.Hasegawa-Nakamura K, Tateishi F, Nakamura T, Nakajima Y, Kawamata K, Douchi T, Hatae M, Noguchi K. The possible mechanism of preterm birth associated with periodontopathic Porphyromonas gingivalis. J Periodontal Res. 2011;46:497–504. doi: 10.1111/j.1600-0765.2011.01366.x. [DOI] [PubMed] [Google Scholar]
  • 45.Takeuchi Y, Umeda M, Sakamoto M, Benno Y, Huang Y, Ishikawa I. Treponema socranskii, Treponema denticola, and Porphyromonas gingivalis are associated with severity of periodontal tissue destruction. J Periodontol. 2001;72(10):1354–1363. doi: 10.1902/jop.2001.72.10.1354. [DOI] [PubMed] [Google Scholar]
  • 46.Ruiz DR, Romito GA, Dib SA. Periodontal disease in gestational and type 1 diabetes mellitus pregnant women. Oral Dis. 2011;17(5):515–521. doi: 10.1111/j.1601-0825.2011.01805.x. [DOI] [PubMed] [Google Scholar]
  • 47.Novak KF, Taylor GW, Dolphus R, et al. Periodontitis and gestational diabetes mellitus: exploring the link in NHANES III. J Public Health Dent. 2006;66(3):163–168. doi: 10.1111/j.1752-7325.2006.tb02574.x. [DOI] [PubMed] [Google Scholar]
  • 48.Ebersole JL, Novak MJ, Michalowicz BS, Hodges JS, Steffen MJ, Ferguson JE, DiAngelis A, Buchanan W, Mitchell DA, Papapanou PN. Systemic immune responses in pregnancy and periodontitis: relationship to pregnancy outcomes in the obstetrics and periodontal therapy (OPT) study. J Periodontol. 2009;80(6):953–960. doi: 10.1902/jop.2009.080464. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Diabetes and Metabolic Disorders are provided here courtesy of Springer

RESOURCES